Related references
Note: Only part of the references are listed.Entecavir Monotherapy Is Effective in Suppressing Hepatitis B Virus After Liver Transplantation
James Fung et al.
GASTROENTEROLOGY (2011)
Hepatocellular carcinoma is associated with an increased risk of hepatitis B virus recurrence after liver transplantation
Luciana C. Faria et al.
GASTROENTEROLOGY (2008)
A Randomized Study of Adefovir Dipivoxil in Place of HBIG in Combination with Lamivudine As Post-Liver Transplantation Hepatitis B Prophylaxis
Peter W. Angus et al.
HEPATOLOGY (2008)
Lamivudine plus low-dose hepatitis B immunoglobulin to prevent recurrent hepatitis B following liver transplantation
Edward J. Gane et al.
GASTROENTEROLOGY (2007)
Liver transplantation for chronic hepatitis B with lamivudine-resistant YMDD mutant using add-on adefovir dipivoxil plus lamivudine
CM Lo et al.
LIVER TRANSPLANTATION (2005)
Is triple vs. dual drug therapy associated with increased risk of death due to malignancy in adult liver transplant recipients?
JR Lake et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
Viral load at the time of liver transplantation and risk of hepatitis B virus recurrence
A Marzano et al.
LIVER TRANSPLANTATION (2005)
Differential effects of donor age in liver transplant recipients infected with hepatitis B, hepatitis C and without viral hepatitis
JR Lake et al.
AMERICAN JOURNAL OF TRANSPLANTATION (2005)
A randomized study comparing lamivudine monotherapy after a short course of hepatitis B immune globulin (HBIg) and lamivudine with long-term lamivudine plus HBIg in the prevention of hepatitis B virus recurrence after liver transplantation
M Buti et al.
JOURNAL OF HEPATOLOGY (2003)
A multicenter United States-Canadian trial to assess lamivudine monotherapy before and after liver transplantation for chronic hepatitis
RP Perrillo et al.
HEPATOLOGY (2001)
Liver transplantation in Asian patients with chronic hepatitis B using lamivudine prophylaxis
CM Lo et al.
ANNALS OF SURGERY (2001)
Lamivudine without HBIg for prevention of graft reinfection by hepatitis B: Long-term follow-up
D Mutimer et al.
TRANSPLANTATION (2000)
Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B
PW Angus et al.
LIVER TRANSPLANTATION (2000)
Share Paper
